X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (35908) 35908
Publication (4864) 4864
Book Review (513) 513
Newspaper Article (370) 370
Book Chapter (250) 250
Book / eBook (174) 174
Newsletter (95) 95
Magazine Article (62) 62
Conference Proceeding (41) 41
Trade Publication Article (22) 22
Dissertation (18) 18
Data Set (15) 15
Transcript (8) 8
Paper (5) 5
Report (4) 4
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (29439) 29439
index medicus (22143) 22143
female (16629) 16629
male (15939) 15939
viral load (14510) 14510
adult (13341) 13341
infectious diseases (10801) 10801
middle aged (10639) 10639
hiv infections - drug therapy (9449) 9449
hiv (9094) 9094
virology (8833) 8833
immunology (8397) 8397
health aspects (7495) 7495
infection (6408) 6408
animals (6394) 6394
hiv infections - virology (6064) 6064
treatment outcome (5992) 5992
viruses (5870) 5870
infections (5601) 5601
human immunodeficiency virus--hiv (5501) 5501
antiviral agents - therapeutic use (5469) 5469
microbiology (5047) 5047
research article (4865) 4865
research (4852) 4852
virus diseases (4833) 4833
antiviral agents (4795) 4795
anti-hiv agents - therapeutic use (4771) 4771
cd4 lymphocyte count (4753) 4753
analysis (4690) 4690
antiretroviral therapy (4626) 4626
medicine (4456) 4456
drug therapy (4240) 4240
aids (4230) 4230
aged (4039) 4039
hiv infection (3986) 3986
therapy (3864) 3864
genotype (3807) 3807
drug therapy, combination (3789) 3789
risk factors (3754) 3754
hiv-1 - drug effects (3673) 3673
gastroenterology & hepatology (3633) 3633
hiv infections - immunology (3618) 3618
rna, viral - blood (3488) 3488
care and treatment (3404) 3404
multidisciplinary sciences (3387) 3387
science (3373) 3373
adolescent (3368) 3368
young adult (3311) 3311
human immunodeficiency virus (3267) 3267
hiv-1 - genetics (3241) 3241
acquired immune deficiency syndrome--aids (3145) 3145
human-immunodeficiency-virus (3091) 3091
hepatitis (2979) 2979
hepatitis c (2975) 2975
antiretroviral therapy, highly active (2873) 2873
mutation (2864) 2864
article (2862) 2862
antiretroviral drugs (2820) 2820
viral infections (2778) 2778
interferon (2750) 2750
hepatitis c virus (2717) 2717
pharmacology & pharmacy (2713) 2713
highly active antiretroviral therapy (2683) 2683
hepacivirus - genetics (2660) 2660
mice (2634) 2634
hepatitis c, chronic - drug therapy (2609) 2609
rna (2558) 2558
time factors (2469) 2469
retrospective studies (2447) 2447
proteins (2427) 2427
biology (2392) 2392
medical research (2387) 2387
drug resistance, viral (2370) 2370
disease (2369) 2369
hiv-1 (2333) 2333
drug resistance (2323) 2323
patients (2320) 2320
genetic aspects (2246) 2246
mortality (2188) 2188
acquired immune deficiency syndrome (2176) 2176
viral diseases (2170) 2170
replication (2169) 2169
antibodies (2147) 2147
cohort studies (2136) 2136
prevalence (2105) 2105
hiv infections - complications (2098) 2098
disease progression (2066) 2066
prospective studies (2065) 2065
t cells (2050) 2050
epidemiology (2003) 2003
studies (1996) 1996
lymphocytes (1972) 1972
interferon-alpha - therapeutic use (1953) 1953
active antiretroviral therapy (1951) 1951
antiviral agents - pharmacology (1905) 1905
viral load - drug effects (1903) 1903
prevention (1866) 1866
hepatitis b (1857) 1857
dna (1851) 1851
medicine and health sciences (1844) 1844
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (131) 131
Collection Dvlpm't (Acquisitions) - Vendor file (16) 16
Collection Dvlpm't (Acquisitions) - Closed Orders (14) 14
UofT at Mississauga - Stacks (9) 9
Online Resources - Online (8) 8
UofT at Scarborough - Stacks (6) 6
Robarts - Stacks (3) 3
UTL at Downsview - May be requested (3) 3
Earth Sciences (Noranda) - Stacks (2) 2
Gerstein Science - Course Reserves (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
Credit Valley Hospital - Stacks (1) 1
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (1) 1
Gerstein Science - Circulation Desk (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Law (Bora Laskin) - Stacks (1) 1
New College (Ivey) - Stacks (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
Trinity College (John W Graham) - Stacks (1) 1
University College (Laidlaw) - Stacks (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (36226) 36226
German (151) 151
Spanish (150) 150
Chinese (104) 104
French (86) 86
Russian (29) 29
Portuguese (20) 20
Polish (17) 17
Dutch (10) 10
Italian (10) 10
Japanese (10) 10
Korean (6) 6
Hungarian (5) 5
Czech (3) 3
Turkish (2) 2
Ukrainian (2) 2
Arabic (1) 1
Danish (1) 1
Romanian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS Pathogens, ISSN 1553-7366, 2015, Volume 11, Issue 9, p. e1005142
Pharmacologically-induced activation of replication competent proviruses from latency in the presence of antiretroviral treatment (ART) has been proposed as a... 
ACTIVATION | RNA | PERSISTENCE | CD4(+) T-CELLS | MICROBIOLOGY | VIROLOGY | HISTONE DEACETYLASES | ACTIVE ANTIRETROVIRAL THERAPY | IMMUNODEFICIENCY-VIRUS TYPE-1 | STEM-CELL | INFECTION | PARASITOLOGY | VIRAL RESERVOIR | Follow-Up Studies | Humans | Middle Aged | Antiretroviral Therapy, Highly Active - adverse effects | Male | RNA, Viral - blood | AIDS Vaccines - therapeutic use | Virus Latency - drug effects | AIDS Vaccines - adverse effects | Anti-HIV Agents - administration & dosage | HIV Infections - immunology | Drug Interactions | HIV-1 - physiology | Lymphocytes - immunology | Protein Processing, Post-Translational - drug effects | HIV-1 - isolation & purification | Adult | Anti-HIV Agents - therapeutic use | Female | Depsipeptides - therapeutic use | RNA, Viral - metabolism | Depsipeptides - adverse effects | Biomarkers - metabolism | Lymphocytes - metabolism | HIV-1 - drug effects | Anti-HIV Agents - adverse effects | HIV Infections - virology | Biomarkers - blood | Histones - blood | Acetylation - drug effects | HIV-1 - immunology | Virus Activation - drug effects | Lymphocytes - drug effects | HIV Infections - drug therapy | Histones - metabolism | Infusions, Intravenous | Viral Load - drug effects | Cohort Studies | Depsipeptides - administration & dosage | HIV Infections - metabolism | Studies | Plasma | HIV | Acquired immune deficiency syndrome | Cytokines | Lymphocytes | Curing | AIDS | Infections | Human immunodeficiency virus | Research | Drug therapy
Journal Article
Nature, ISSN 0028-0836, 02/2016, Volume 530, Issue 7588, pp. 51 - 56
Journal Article
Nature, ISSN 0028-0836, 12/2015, Volume 528, Issue 7580, pp. S68 - S76
Journal Article
Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9987, pp. 2606 - 2615
Summary Background Tenofovir disoproxil fumarate can cause renal and bone toxic effects related to high plasma tenofovir concentrations. Tenofovir alafenamide... 
Internal Medicine | KIDNEY-DISEASE | RATES | MEDICINE, GENERAL & INTERNAL | ABACAVIR-LAMIVUDINE | BONE-MINERAL DENSITY | SAFETY | ADULTS | ANTIRETROVIRAL THERAPY | LOPINAVIR/RITONAVIR | COUNT | EXPOSURE | Humans | Male | Thiazoles - administration & dosage | Carbamates - administration & dosage | Arthralgia - chemically induced | Thiazoles - adverse effects | Sleep Initiation and Maintenance Disorders - chemically induced | Tenofovir | Adenine - adverse effects | Quinolones - adverse effects | Adult | Anti-HIV Agents - therapeutic use | Deoxycytidine - adverse effects | Female | Headache - chemically induced | Emtricitabine | Adenine - analogs & derivatives | Kidney - drug effects | Respiration Disorders - chemically induced | Double-Blind Method | Anti-HIV Agents - adverse effects | Deoxycytidine - administration & dosage | HIV Infections - virology | Organophosphonates - adverse effects | Treatment Outcome | CD4 Lymphocyte Count | Nausea | Adenine - administration & dosage | Organophosphonates - administration & dosage | Bone Density - drug effects | Quinolones - administration & dosage | Carbamates - adverse effects | HIV Infections - drug therapy | Viral Load - drug effects | Cobicistat | Deoxycytidine - analogs & derivatives | Drug Combinations | Medical colleges | Clinical trials | Cross infection | Nosocomial infections | HIV (Viruses) | Drug therapy | Health aspects | HIV infection | Analysis | Antiretroviral drugs | Infections | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV
Journal Article
Nature, ISSN 0028-0836, 07/2016, Volume 535, Issue 7613, pp. 556 - 560
Interruption of combination antiretroviral therapy in HIV-1-infected individuals leads to rapid viral rebound. Here we report the results of a phase IIa open... 
POTENT | REPLICATION | GENETIC-DETERMINANTS | BROADLY NEUTRALIZING ANTIBODIES | MULTIDISCIPLINARY SCIENCES | PASSIVE TRANSFER | SEQUENCE | CD4 BINDING | ANTIRETROVIRAL THERAPY | INFECTION | MONOCLONAL-ANTIBODIES | Anti-HIV Agents - pharmacology | Antibodies, Neutralizing - administration & dosage | Disease Reservoirs - virology | Humans | Middle Aged | Male | Proviruses - immunology | Anti-HIV Agents - administration & dosage | Tissue Distribution | Young Adult | HIV Infections - immunology | Proviruses - drug effects | Antibodies, Neutralizing - immunology | HIV-1 - growth & development | HIV Antibodies - immunology | HIV Envelope Protein gp160 - chemistry | Time Factors | Antibodies, Neutralizing - therapeutic use | Binding Sites - immunology | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Antibodies - therapeutic use | Historically Controlled Study | Binding Sites - drug effects | HIV Envelope Protein gp160 - metabolism | Drug Administration Schedule | HIV-1 - drug effects | HIV Infections - virology | HIV Antibodies - administration & dosage | Viral Load - immunology | Proviruses - growth & development | HIV-1 - immunology | HIV Envelope Protein gp160 - antagonists & inhibitors | Adolescent | HIV Infections - drug therapy | Aged | HIV Envelope Protein gp160 - immunology | Viral Load - drug effects | CD4 Antigens - metabolism | Prevention | Antiviral agents | HIV antibodies | Dosage and administration | Host-virus relationships | Drug therapy, Combination | Drug therapy | Health aspects | HIV infection | Methods | Clinical trials | Antiretroviral drugs | Immunoglobulins | Human immunodeficiency virus--HIV | Binding sites
Journal Article
Lancet, The, ISSN 0140-6736, 2010, Volume 376, Issue 9755, pp. 1838 - 1845
Journal Article
Nature, ISSN 0028-0836, 06/2015, Volume 522, Issue 7557, pp. 487 - 491
HIV-1 immunotherapy with a combination of first generation monoclonal antibodies was largely ineffective in pre-clinical and clinical settings and was... 
THERAPY | VIRUS | HIV-1 NEUTRALIZATION | GENETIC-DETERMINANTS | IMMUNOTHERAPY | MULTIDISCIPLINARY SCIENCES | PASSIVE TRANSFER | IN-VIVO | VACCINE | MICE | MONOCLONAL-ANTIBODIES | Antibodies, Neutralizing - administration & dosage | Humans | Middle Aged | Viremia - therapy | Molecular Sequence Data | Antibodies, Monoclonal - therapeutic use | Male | Case-Control Studies | HIV Envelope Protein gp120 - immunology | Young Adult | HIV Infections - immunology | Antibodies, Neutralizing - immunology | HIV Antibodies - adverse effects | HIV Antibodies - immunology | Time Factors | HIV-1 - chemistry | Antibodies, Neutralizing - therapeutic use | Adult | Antibodies, Neutralizing - adverse effects | Female | HIV Antibodies - therapeutic use | HIV Envelope Protein gp120 - chemistry | HIV Antibodies - pharmacology | Binding Sites | Antibodies, Monoclonal - immunology | Amino Acid Sequence | Immunization, Passive - methods | HIV-1 - drug effects | HIV Infections - virology | Antibodies, Monoclonal - pharmacokinetics | Antibodies, Neutralizing - pharmacology | HIV Antibodies - administration & dosage | Viral Load - immunology | HIV-1 - immunology | Viremia - virology | Antibodies, Monoclonal - administration & dosage | HIV Infections - therapy | Viremia - immunology | Viral Load - drug effects | CD4 Antigens - metabolism | Evolution, Molecular | Viral antibodies | Virus diseases | Physiological aspects | Antibodies | HIV infection | Antigens | Immunoglobulins | Human immunodeficiency virus--HIV | Immunotherapy | Infections | Drug dosages | Binding sites | Immune system
Journal Article